What Trump’s Executive Order On Ibogaine Means For Veterans With PTSD

President Trump ordered federal agencies to study ibogaine as a potential treatment for veterans with PTSD, traumatic brain injury, and opioid dependence.

The order does not legalize the drug; ibogaine remains a Schedule I controlled substance under federal law.

Still, the move could legitimize psychedelic medicine research and speed up evidence gathering on a high-risk therapy.

FDA and DEA involvement may help advance clinical review and research into possible benefits for veterans.